Switzerland
KD Pharma Group, with the slogan "Creating Health Solutions", stands as a distinguished CDMO specializing in the development of pharmaceutical and nutraceutical products. Established in 1988, the company has carved a significant position in the Life Sciences and Pharmaceutical industries.
As the leading global producer of APIs for Omega-3 pharmaceuticals, KD Pharma Group has also achieved a dominant status in Omega-3 nutraceuticals through comprehensive formulation and encapsulation services. Headquartered in Switzerland, their operations span across multiple strategic locations including the UK, Norway, Germany, Switzerland, and the US, supported by over 500 employees.
The company leverages cutting-edge technology protected by numerous patents, underscoring its commitment to innovation and quality. However, it has not recently reported any new investments or investors, suggesting potential opportunities for financial engagement and partnership to further enhance its market leadership and technological advancements.
